{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T16:11:18Z","timestamp":1694880678909},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2002,9,1]]},"DOI":"10.1038\/sj.bmt.1703627","type":"journal-article","created":{"date-parts":[[2002,9,9]],"date-time":"2002-09-09T11:00:37Z","timestamp":1031569237000},"page":"279-285","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis"],"prefix":"10.1038","volume":"30","author":[{"given":"BM","family":"Hayes-Lattin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PT","family":"Curtin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WH","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JF","family":"Leis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DE","family":"Stepan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Schubach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RT","family":"Maziarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,9,3]]},"reference":[{"key":"BF1703627_CR1","first-page":"45","volume":"32","author":"RA Kyle","year":"1995","unstructured":"Kyle RA, Gertz MA . Primary systemic amyloidosis: clinical and laboratory features in 474 cases Semin Hematol 1995 32: 45 59","journal-title":"Semin Hematol"},{"key":"BF1703627_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","volume":"100","author":"M Skinner","year":"1996","unstructured":"Skinner M, Anderson J, Simms R et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only Am J Med 1996 100: 290 298","journal-title":"Am J Med"},{"key":"BF1703627_CR3","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","volume":"336","author":"RA Kyle","year":"1997","unstructured":"Kyle RA, Gertz MA, Greipp PR et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine New Engl J Med 1997 336: 1202 1207","journal-title":"New Engl J Med"},{"key":"BF1703627_CR4","first-page":"S234","volume":"41","author":"Z Amoura","year":"1998","unstructured":"Amoura Z, Leblond V, Azar N et al. High dose therapy and autologous stem cell transplantation (ASCT) for systemic amyloidosis (AL): report of 9 cases (abstract) Arthritis Rheum 1998 41: S234","journal-title":"Arthritis Rheum"},{"key":"BF1703627_CR5","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1046\/j.1365-2141.1998.00772.x","volume":"101","author":"P Moreau","year":"1998","unstructured":"Moreau P, Leblond V, Bourquelot P et al. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients Br J Haematol 1998 101: 766 769","journal-title":"Br J Haematol"},{"key":"BF1703627_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.7326\/0003-4819-123-7-199510010-00018","volume":"123","author":"HM Lokhorst","year":"1995","unstructured":"Lokhorst HM, Verdonck LF . Intensive therapy in AL amyloidosis and light-chain deposition disease (letter) Ann Intern Med 1995 123: 553","journal-title":"Ann Intern Med"},{"key":"BF1703627_CR7","first-page":"324a","volume":"92","author":"RL Comenzo","year":"1998","unstructured":"Comenzo RL, Falk RH, Sanchorawala V et al. Treating AL amyloidosis (AL) with dose-intensive melphalan: outcomes in 102 patients Blood 1998 92: 324a","journal-title":"Blood"},{"key":"BF1703627_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/sj.bmt.1702178","volume":"25","author":"MA Gertz","year":"2000","unstructured":"Gertz MA, Lacy MQ, Dispenzieri A . Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report Bone Marrow Transplant 2000 25: 465 470","journal-title":"Bone Marrow Transplant"},{"key":"BF1703627_CR9","doi-asserted-by":"publisher","first-page":"746","DOI":"10.7326\/0003-4819-134-9_Part_1-200105010-00011","volume":"134","author":"LM Dember","year":"2001","unstructured":"Dember LM, Sanchorawala V, Seldin DC et al. Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease Ann Intern Med 2001 134: 746 753","journal-title":"Ann Intern Med"},{"key":"BF1703627_CR10","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bmt.1702643","volume":"26","author":"MA Gertz","year":"2000","unstructured":"Gertz MA, Lacy MQ, Gastineau DA et al. Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL) Bone Marrow Transplant 2000 26: 963 969","journal-title":"Bone Marrow Transplant"},{"key":"BF1703627_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/sj.bmt.1703200","volume":"28","author":"V Sanchorawala","year":"2001","unstructured":"Sanchorawala V, Wright DG, Seldin DC et al. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis Bone Marrow Transplant 2001 28: 637 642","journal-title":"Bone Marrow Transplant"},{"key":"BF1703627_CR12","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V91.10.3662","volume":"91","author":"RL Comenzo","year":"1998","unstructured":"Comenzo RL, Vosburgh E, Falk RH et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients Blood 1998 91: 3662 3670","journal-title":"Blood"},{"key":"BF1703627_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/sj.bmt.1702766","volume":"27","author":"G Reich","year":"2001","unstructured":"Reich G, Held T, Siegert W et al. Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation Bone Marrow Transplant 2001 27: 341 343","journal-title":"Bone Marrow Transplant"},{"key":"BF1703627_CR14","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V87.7.3063.bloodjournal8773063","volume":"87","author":"P Moreau","year":"1996","unstructured":"Moreau P, Milpied N, de Faucal P et al. High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement Blood 1996 87: 3063 3064","journal-title":"Blood"},{"key":"BF1703627_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/sj.bmt.1701925","volume":"24","author":"F Patriarca","year":"1999","unstructured":"Patriarca F, Geromin A, Fanin R et al. Improvement of amyloid-related symptoms after autologous stem cell transplantation in a patient with hepatomegaly, macroglossia and purpura Bone Marrow Transplant 1999 24: 433 435","journal-title":"Bone Marrow Transplant"},{"key":"BF1703627_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/sj.bmt.1701765","volume":"23","author":"O Sezer","year":"1999","unstructured":"Sezer O, Schmid P, Shweigert M et al. Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support Bone Marrow Transplant 1999 23: 967 969","journal-title":"Bone Marrow Transplant"},{"key":"BF1703627_CR17","unstructured":"Anonymous. National Cancer Institute Common Toxicity Criteria. version 2.0 April 30 1999"},{"key":"BF1703627_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1083-8791(98)90008-8","volume":"4","author":"SP Tzung","year":"1998","unstructured":"Tzung SP, Hackman RC, Hockenbery DM et al. Lymphocytic gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantation Biol Blood Marrow Transplant 1998 4: 43 48","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1703627_CR19","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/sj.leu.2401593","volume":"13","author":"P Moreau","year":"1999","unstructured":"Moreau P . Autologous stem cell transplantation for AL amyloidosis: a standard therapy? Leukemia 1999 13: 1929 1931","journal-title":"Leukemia"},{"key":"BF1703627_CR20","first-page":"844","volume":"84","author":"I Majolino","year":"1999","unstructured":"Majolino I, Vignetti M, Meloni G et al. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo Haematologica 1999 84: 844 852","journal-title":"Haematologica"},{"key":"BF1703627_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome New Engl J Med 1996 335: 91 97","journal-title":"New Engl J Med"},{"key":"BF1703627_CR22","first-page":"1087","volume":"326","author":"J Mehta","year":"1992","unstructured":"Mehta J, Nagler A, Slavin S . Marrow transplantation in multiple myeloma New Engl J Med 1992 326: 1087 discussion 1087 1088","journal-title":"New Engl J Med"},{"key":"BF1703627_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.bmt.1701330","volume":"22","author":"A Schulenburg","year":"1998","unstructured":"Schulenburg A, Kalhs P, Oberhuber G et al. Gastrointestinal perforation early after peripheral blood stem cell transplantation for AL amyloidosis Bone Marrow Transplant 1998 22: 293 295","journal-title":"Bone Marrow Transplant"},{"key":"BF1703627_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/10428190009089426","volume":"37","author":"RL Comenzo","year":"2000","unstructured":"Comenzo RL . Hematopoietic cell transplantation for primary systemic amyloidosis: what have we learned Leuk Lymphoma 2000 37: 245 258","journal-title":"Leuk Lymphoma"},{"key":"BF1703627_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0140-6736(97)10475-5","volume":"351","author":"SG Sheth","year":"1998","unstructured":"Sheth SG, LaMont JT . Toxic megacolon Lancet 1998 351: 509 513","journal-title":"Lancet"},{"key":"BF1703627_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0037-198X(86)90029-5","volume":"21","author":"HC Carlson","year":"1986","unstructured":"Carlson HC, Breen JF . Amyloidosis and plasma cell dyscrasias: gastrointestinal involvement Semin Roentgenol 1986 21: 128 138","journal-title":"Semin Roentgenol"},{"key":"BF1703627_CR27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/blood.V68.1.220.220","volume":"68","author":"RA Kyle","year":"1986","unstructured":"Kyle RA, Greipp PR, O'Fallon WM . Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases Blood 1986 68: 220 224","journal-title":"Blood"},{"key":"BF1703627_CR28","volume-title":"Cancer Chemotherapy and Biotherapy. 3rd edn","author":"BA Chabner","year":"2001","unstructured":"Chabner BA, Longo DL . Cancer Chemotherapy and Biotherapy. 3rd edn Lippincott Williams and Wilkins: Philadelphia 2001"},{"key":"BF1703627_CR29","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/sj.bmt.1702005","volume":"24","author":"N Saba","year":"1999","unstructured":"Saba N, Sutton D, Ross H et al. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant Bone Marrow Transplant 1999 24: 853 855","journal-title":"Bone Marrow Transplant"},{"key":"BF1703627_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3109\/10428199709059685","volume":"27","author":"KR Desikan","year":"1997","unstructured":"Desikan KR, Dhodapkar MV, Hough A et al. Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation Leuk Lymphoma 1997 27: 315 319","journal-title":"Leuk Lymphoma"},{"key":"BF1703627_CR31","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1200\/JCO.2001.19.14.3350","volume":"19","author":"A Dispenzieri","year":"2001","unstructured":"Dispenzieri A, Lacy MQ, Kyle RA et al. Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival J Clin Oncol 2001 19: 3350 3356","journal-title":"J Clin Oncol"},{"key":"BF1703627_CR32","first-page":"85","volume":"11","author":"I Majolino","year":"1993","unstructured":"Majolino I, Marceno R, Pecoraro G et al. Autologous stem cell transplantation in amyloidosis AL Bone Marrow Transplant 1993 11: 85","journal-title":"Bone Marrow Transplant"},{"key":"BF1703627_CR33","doi-asserted-by":"publisher","first-page":"508","DOI":"10.7326\/0003-4819-122-7-199504010-00005","volume":"122","author":"M van Buren","year":"1995","unstructured":"van Buren M, Hene RJ, Verdonck LF et al. Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis Ann Intern Med 1995 122: 508 510","journal-title":"Ann Intern Med"},{"key":"BF1703627_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1365-2141.1997.303194.x","volume":"99","author":"JD Gillmore","year":"1997","unstructured":"Gillmore JD, Hawkins PN, Pepys MB . Amyloidosis: a review of recent diagnostic and therapeutic developments Br J Haematol 1997 99: 245 256","journal-title":"Br J Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703627","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703627.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703627.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:25:59Z","timestamp":1648077959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,1]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,9,1]]}},"alternative-id":["BF1703627"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703627","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9,1]]},"assertion":[{"value":"18 December 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}